Sialoblastoma: Clinicopathological/immunohistochemical study

Margaret Brandwein, Nasser Said Al-Naeif, Deepa G. Manwani, Peter Som, Lara Goldfeder, Michael Rothschild, Linda Granowetter

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Sialoblastoma is an extremely rare salivary tumor diagnosed at birth or shortly thereafter with significant variability in histologic range and clinical course, so that for an individual case it may be difficult to predict the most appropriate therapy. We detail the case of a toddler noted to have a firm l-2-cm mass in the left cheek at 21 months. Parotidectomy was performed at 26 months, revealing a sialoblastoma; the resection margins were positive. During the next 10 months, the mass recurred or persisted, necessitating numerous procedures. The tumor was composed of basaloid cells with fine chromatin and other more mature cuboidal epithelial cells. Ductules and solid organoid nests with some tendency toward peripheral pallisading were also noted. There was no perineural invasion; necrosis initially was sparse but increased over time. The mitotic rate also increased from 6 to 7/10 high-power fields in the first resection to 20/10 high-power fields in the last resection. Nuclear pleomorphism increased with time. The MiB1 proliferative index revealed a dramatic increase in the number of labeled nuclei: from 3 cells/10 high-power fields in the first specimen to 94 cells/10 high-power fields for the last specimen. Cytokeratin accentuated the ductal structures. S-100 showed a diffuse staining pattern, with darker staining of the spindled myoepithelial cells. The Her-2-neu protein showed moderate cytoplasmic staining, whereas the p53 showed only occasional labeling of nuclei. This is the first case of sialoblastoma with evidence of increasing anaplasia based on increasing proliferative capacity. Therefore, the distinction between benign and malignant sialoblastomas may not be as well defined as previously thought. The patient's prognosis is likely to be determined by the tumor grade as well as the stage at presentation and the extent of resection.

Original languageEnglish (US)
Pages (from-to)342-348
Number of pages7
JournalAmerican Journal of Surgical Pathology
Volume23
Issue number3
DOIs
StatePublished - Mar 1999
Externally publishedYes

Fingerprint

Staining and Labeling
Anaplasia
Organoids
Neoplasms
Cheek
Keratins
Cell Nucleus
Chromatin
Necrosis
Epithelial Cells
Parturition
Proteins
Therapeutics
Margins of Excision

Keywords

  • MiB1
  • Pediatric
  • Salivary tumor
  • Sialoblastoma

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine

Cite this

Brandwein, M., Al-Naeif, N. S., Manwani, D. G., Som, P., Goldfeder, L., Rothschild, M., & Granowetter, L. (1999). Sialoblastoma: Clinicopathological/immunohistochemical study. American Journal of Surgical Pathology, 23(3), 342-348. https://doi.org/10.1097/00000478-199903000-00015

Sialoblastoma : Clinicopathological/immunohistochemical study. / Brandwein, Margaret; Al-Naeif, Nasser Said; Manwani, Deepa G.; Som, Peter; Goldfeder, Lara; Rothschild, Michael; Granowetter, Linda.

In: American Journal of Surgical Pathology, Vol. 23, No. 3, 03.1999, p. 342-348.

Research output: Contribution to journalArticle

Brandwein, M, Al-Naeif, NS, Manwani, DG, Som, P, Goldfeder, L, Rothschild, M & Granowetter, L 1999, 'Sialoblastoma: Clinicopathological/immunohistochemical study', American Journal of Surgical Pathology, vol. 23, no. 3, pp. 342-348. https://doi.org/10.1097/00000478-199903000-00015
Brandwein, Margaret ; Al-Naeif, Nasser Said ; Manwani, Deepa G. ; Som, Peter ; Goldfeder, Lara ; Rothschild, Michael ; Granowetter, Linda. / Sialoblastoma : Clinicopathological/immunohistochemical study. In: American Journal of Surgical Pathology. 1999 ; Vol. 23, No. 3. pp. 342-348.
@article{710293f03e7445f0a77d581ae6af6f1c,
title = "Sialoblastoma: Clinicopathological/immunohistochemical study",
abstract = "Sialoblastoma is an extremely rare salivary tumor diagnosed at birth or shortly thereafter with significant variability in histologic range and clinical course, so that for an individual case it may be difficult to predict the most appropriate therapy. We detail the case of a toddler noted to have a firm l-2-cm mass in the left cheek at 21 months. Parotidectomy was performed at 26 months, revealing a sialoblastoma; the resection margins were positive. During the next 10 months, the mass recurred or persisted, necessitating numerous procedures. The tumor was composed of basaloid cells with fine chromatin and other more mature cuboidal epithelial cells. Ductules and solid organoid nests with some tendency toward peripheral pallisading were also noted. There was no perineural invasion; necrosis initially was sparse but increased over time. The mitotic rate also increased from 6 to 7/10 high-power fields in the first resection to 20/10 high-power fields in the last resection. Nuclear pleomorphism increased with time. The MiB1 proliferative index revealed a dramatic increase in the number of labeled nuclei: from 3 cells/10 high-power fields in the first specimen to 94 cells/10 high-power fields for the last specimen. Cytokeratin accentuated the ductal structures. S-100 showed a diffuse staining pattern, with darker staining of the spindled myoepithelial cells. The Her-2-neu protein showed moderate cytoplasmic staining, whereas the p53 showed only occasional labeling of nuclei. This is the first case of sialoblastoma with evidence of increasing anaplasia based on increasing proliferative capacity. Therefore, the distinction between benign and malignant sialoblastomas may not be as well defined as previously thought. The patient's prognosis is likely to be determined by the tumor grade as well as the stage at presentation and the extent of resection.",
keywords = "MiB1, Pediatric, Salivary tumor, Sialoblastoma",
author = "Margaret Brandwein and Al-Naeif, {Nasser Said} and Manwani, {Deepa G.} and Peter Som and Lara Goldfeder and Michael Rothschild and Linda Granowetter",
year = "1999",
month = "3",
doi = "10.1097/00000478-199903000-00015",
language = "English (US)",
volume = "23",
pages = "342--348",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Sialoblastoma

T2 - Clinicopathological/immunohistochemical study

AU - Brandwein, Margaret

AU - Al-Naeif, Nasser Said

AU - Manwani, Deepa G.

AU - Som, Peter

AU - Goldfeder, Lara

AU - Rothschild, Michael

AU - Granowetter, Linda

PY - 1999/3

Y1 - 1999/3

N2 - Sialoblastoma is an extremely rare salivary tumor diagnosed at birth or shortly thereafter with significant variability in histologic range and clinical course, so that for an individual case it may be difficult to predict the most appropriate therapy. We detail the case of a toddler noted to have a firm l-2-cm mass in the left cheek at 21 months. Parotidectomy was performed at 26 months, revealing a sialoblastoma; the resection margins were positive. During the next 10 months, the mass recurred or persisted, necessitating numerous procedures. The tumor was composed of basaloid cells with fine chromatin and other more mature cuboidal epithelial cells. Ductules and solid organoid nests with some tendency toward peripheral pallisading were also noted. There was no perineural invasion; necrosis initially was sparse but increased over time. The mitotic rate also increased from 6 to 7/10 high-power fields in the first resection to 20/10 high-power fields in the last resection. Nuclear pleomorphism increased with time. The MiB1 proliferative index revealed a dramatic increase in the number of labeled nuclei: from 3 cells/10 high-power fields in the first specimen to 94 cells/10 high-power fields for the last specimen. Cytokeratin accentuated the ductal structures. S-100 showed a diffuse staining pattern, with darker staining of the spindled myoepithelial cells. The Her-2-neu protein showed moderate cytoplasmic staining, whereas the p53 showed only occasional labeling of nuclei. This is the first case of sialoblastoma with evidence of increasing anaplasia based on increasing proliferative capacity. Therefore, the distinction between benign and malignant sialoblastomas may not be as well defined as previously thought. The patient's prognosis is likely to be determined by the tumor grade as well as the stage at presentation and the extent of resection.

AB - Sialoblastoma is an extremely rare salivary tumor diagnosed at birth or shortly thereafter with significant variability in histologic range and clinical course, so that for an individual case it may be difficult to predict the most appropriate therapy. We detail the case of a toddler noted to have a firm l-2-cm mass in the left cheek at 21 months. Parotidectomy was performed at 26 months, revealing a sialoblastoma; the resection margins were positive. During the next 10 months, the mass recurred or persisted, necessitating numerous procedures. The tumor was composed of basaloid cells with fine chromatin and other more mature cuboidal epithelial cells. Ductules and solid organoid nests with some tendency toward peripheral pallisading were also noted. There was no perineural invasion; necrosis initially was sparse but increased over time. The mitotic rate also increased from 6 to 7/10 high-power fields in the first resection to 20/10 high-power fields in the last resection. Nuclear pleomorphism increased with time. The MiB1 proliferative index revealed a dramatic increase in the number of labeled nuclei: from 3 cells/10 high-power fields in the first specimen to 94 cells/10 high-power fields for the last specimen. Cytokeratin accentuated the ductal structures. S-100 showed a diffuse staining pattern, with darker staining of the spindled myoepithelial cells. The Her-2-neu protein showed moderate cytoplasmic staining, whereas the p53 showed only occasional labeling of nuclei. This is the first case of sialoblastoma with evidence of increasing anaplasia based on increasing proliferative capacity. Therefore, the distinction between benign and malignant sialoblastomas may not be as well defined as previously thought. The patient's prognosis is likely to be determined by the tumor grade as well as the stage at presentation and the extent of resection.

KW - MiB1

KW - Pediatric

KW - Salivary tumor

KW - Sialoblastoma

UR - http://www.scopus.com/inward/record.url?scp=0033019258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033019258&partnerID=8YFLogxK

U2 - 10.1097/00000478-199903000-00015

DO - 10.1097/00000478-199903000-00015

M3 - Article

C2 - 10078927

AN - SCOPUS:0033019258

VL - 23

SP - 342

EP - 348

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 3

ER -